Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32472
CAS Number:
78287-27-1
7-Ethylcamptothecin
Purity:
≥ 99% (HPLC)
Synonym(s):
(4S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Hazmat
Documents
$51.18 /250MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Keep container tightly closed in a dry and well-ventilated place.

Synonyms
(4S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
CAS Number
78287-27-1
Purity
≥ 99% (HPLC)
Molecular Formula
C22H20N2O4
Molecular Weight
0
MDL Number
MFCD06657922
PubChem ID
9810521
Melting Point
258 - 260 °C (dec.)
Appearance
Pale yellow needle crystalline powder
Optical Rotation
[a]20/D= 40 to 46 ° (C=0.4 in CHCl3:MeOH=8:2)
Conditions
Store at RT
General Information
Synonyms
(4S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
CAS Number
78287-27-1
Purity
≥ 99% (HPLC)
Molecular Formula
C22H20N2O4
Molecular Weight
0
MDL Number
MFCD06657922
PubChem ID
9810521
Melting Point
258 - 260 °C (dec.)
Appearance
Pale yellow needle crystalline powder
Optical Rotation
[a]20/D= 40 to 46 ° (C=0.4 in CHCl3:MeOH=8:2)
Conditions
Store at RT
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Yes
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

7-Ethylcamptothecin is widely utilized in research focused on:

  • Cancer Treatment: This compound is a potent inhibitor of topoisomerase I, making it a valuable candidate in the development of anti-cancer therapies. It has shown promising results in clinical trials for various cancers, including colorectal and lung cancer.
  • Pharmaceutical Development: Researchers are exploring its potential in formulating new drugs that can overcome resistance seen with traditional chemotherapy agents. Its unique structure allows for modifications that can enhance efficacy and reduce side effects.
  • Drug Delivery Systems: Due to its hydrophobic nature, 7-Ethylcamptothecin can be incorporated into nanocarriers for targeted drug delivery, improving the concentration of the drug at tumor sites while minimizing systemic exposure.
  • Research on Mechanisms of Action: Scientists use this compound to study the mechanisms of DNA damage and repair, providing insights into cellular responses to chemotherapy and helping to identify biomarkers for treatment efficacy.
  • Combination Therapies: It is being investigated in combination with other therapeutic agents to enhance overall treatment outcomes, particularly in resistant cancer types, showcasing its versatility in oncology.

Citations